Witnessing the stock’s movement on the chart, on Wednesday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) had a quiet start as it plunged -4.80% to $3.37, before settling in for the price of $3.54 at the close. Taking a more long-term approach, IRWD posted a 52-week range of $0.53-$5.13.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -47.49%. Meanwhile, its Annual Earning per share during the time was -47.49%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 1448.53%. This publicly-traded company’s shares outstanding now amounts to $162.68 million, simultaneously with a float of $156.69 million. The organization now has a market capitalization sitting at $548.22 million. At the time of writing, stock’s 50-day Moving Average stood at $2.59, while the 200-day Moving Average is $1.40.
Ironwood Pharmaceuticals Inc (IRWD) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Ironwood Pharmaceuticals Inc’s current insider ownership accounts for 3.68%, in contrast to 91.66% institutional ownership. According to the most recent insider trade that took place on Nov 17 ’25, this organization’s Chief Commercial Officer sold 6,016 shares at the rate of 3.32, making the entire transaction reach 19,973 in total value, affecting insider ownership by 235,264.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Let’s observe the current performance indicators for Ironwood Pharmaceuticals Inc (IRWD). It’s Quick Ratio in the last reported quarter now stands at 1.13. Alongside those numbers, its PE Ratio stands at $21.83, and its Beta score is 0.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.62. Similarly, its price to free cash flow for trailing twelve months is now 8.10.
In the same vein, IRWD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.15, a figure that is expected to reach 0.02 in the next quarter, and analysts are predicting that it will be 0.45 at the market close of one year from today.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Going through the that latest performance of [Ironwood Pharmaceuticals Inc, IRWD]. Its last 5-days volume of 2.75 million indicated improvement to the volume of 2.57 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 44.44% While, its Average True Range was 46.23.
Raw Stochastic average of Ironwood Pharmaceuticals Inc (IRWD) in the period of the previous 100 days is set at 82.58%, which indicates a major rise in contrast to 21.13% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.29 that was higher than 0.19 volatility it exhibited in the past 100-days period.
